Funding, News and Announcements

Prostate Cancer Canada (PCC) invites applications for investigator-initiated Special Project in Non-Metastatic Castrate Resistant Prostate Cancer (NM-CRPC). This request for applications (RFA) solicits proposals from groups interested in combining various real world data sources (i.e. detailed chart review at prostate cancer centres with health administrative databases) to obtain high quality epidemiological data, outcomes and costs among the population of prostate cancer patients in at least two provinces in Canada that together represent greater than 50% of the population.

The key objectives of this RFA are:

• to obtain prevalence, incidence and survival probability estimates of prostate cancer, stratified by age and year of diagnosis from provincial cancer registries;
• to identify pathways leading to and factors associated with the target condition (NM-CRPC);
• to estimate annual incidence and prevalence of NM-CRPC, stratified probability of developing NM-CRPC and transition probabilities that characterize the prognosis from NM-CRPC to metastasis and end-of-life;
• to estimate health care resource use and costs for health states in the recurrent disease model.

Award amount: up to $450,000 over 2 years

Key dates:
Registration Deadline: February 3, 2016
Full Application Deadline: February 17, 2016
Funding Start Date: April 1, 2016

For more information and to see the Special Project documents, visit our website.

The link to the online application will be available on the website by December 23, 2015.